Evidence map›Paper›PMID 40861312›Full record

ReviewJournal of hepatocellular carcinoma2025

A Patient Charter to Improve Care for Hepatocellular Carcinoma.

Yasmine Hassan, Achim Kautz, Cary James, Dee Lee, Diane Langenbacher, Eric Bouffet, Jade Chakowa, Jessica Hicks, John W Ward, Lili Anna Kuschnereit and 3 more

Abstract readReview
In one paragraph

Review in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yasmine Hassan *Department of Global Policy, Advocacy and Health Equity, AstraZeneca, Gaithersburg, MD, USA.
Achim Kautz *International Liver Cancer Movement, Cologne, Germany.
Cary James *World Hepatitis Alliance, Geneva, Switzerland.
Dee Lee *Inno Asia, Guangzhou, People's Republic of China.
Diane Langenbacher *International Liver Cancer Movement, Cologne, Germany.
Eric Bouffet *Division of Paediatric Oncology/Haematology, The Hospital for Sick Children, The University of Toronto, Toronto, Canada.
Jade Chakowa *The Hepatitis Fund, Geneva, Switzerland.
Jessica Hicks *World Hepatitis Alliance, Geneva, Switzerland.
John W Ward *Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.
Lili Anna Kuschnereit *Digestive Cancers Europe, Brussels, Belgium.ORCID 0009-0000-4330-3325
Manon Allaire *Service d'Hépato-gastroentérologie, Hôpital Universitaire Pitié-Salpêtrière, AP-HP Sorbonne Université, Paris, France.
Tingting Zhang *Hear2Care, Spokane, WA, USA.ORCID 0009-0002-7591-0706
Zeena Huang Chi *Department of Global Policy, Advocacy and Health Equity, AstraZeneca, Gaithersburg, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To establish a patient charter that articulates the principles of quality care for individuals living with hepatocellular carcinoma (HCC), aiming to improve patient outcomes and survival rates globally. Methods: A multidisciplinary group comprising healthcare professionals, patient advocacy representatives, and policymakers convened to identify the critical areas of unmet need in HCC care. The group shared patient experiences, barriers, and insights - particularly with input from Patient Advocacy Groups (PAGs) - to better understand the challenges faced by patients. They reviewed existing literature, current care practices, and patient experiences to formulate a patient charter that outlines the principles of quality care for HCC. Results: The patient charter identifies the seven principles of quality care that people with HCC or at risk of developing HCC should expect to receive in order to benefit from improved outcomes and increased survival. These principles address the need for policy prioritization, early diagnosis, multidisciplinary care, personalized treatment, shared decision-making, stigma-free access to services and increased research funding. Conclusion: The patient charter serves as a call to action for stakeholders to unite in enhancing the care and treatment of HCC, with the ultimate goal of improving health outcomes for patients.

Indexed as

health policyhepatocellular carcinomaliver cancermultidisciplinary teampatient care

Identifiers

PMID40861312
PMCPMC12375318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.